首站-论文投稿智能助手
典型文献
Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients
文献摘要:
Li-Fraumeni syndrome(LFS),a rare autosomal-dominant inheritance condition,is associated with a family cancer history as well as pathogenic/likely-pathogenic TP53 germline variants(P/LP TP53 GV).The current clinical methods for detecting LFS are limited.Here,we retrospectively investigate P/LP TP53 GV among Chinese cancer patients by next-generation sequencing and evaluate its relationship with a family cancer history.A total of 270 out of 19,226 cancer patients have TP53 GV,including 53 patients with P/LP TP53 GV.Patients with P/LP TP53 GV are mainly found in male with glioma,lung cancer or sarcoma.The median age of diagnosis for P/LP TP53 GV patients is significantly lower than that of non-P/LP TP53 GV patients(31-years vs.53-years;P<0.01).One LFS patient and 3 Li-Fraumeni-like syndrome(LFL)patients are among the 26 followed-up P/LP TP53 GV patients.Among 25 types of P/LP TP53 GV,the highest variant frequencies occurred at codon 175 and 248.p.M2371,p.R158H,p.C238Y and p.C275R,are firstly identified among the Chinese LFS/LFL patients.This study reports the(P/LP)TP53 GV characteristics of Chinese pan-cancer patients.These findings suggest analyzing the P/LP TP53 GV in cancer patients is an effective strategy for identifying cancer predisposition syndrome.
文献关键词:
作者姓名:
Panwen Tian;Xiaoyan Zhang;Sheng Yang;Yu Fang;Hongling Yuan;Wei Li;Honglin Zhu;Fangping Zhao;Jinlei Ding;Yunshu Zhu;Sizhen Wang;Guochen Sun;Hongbin Ni;Tonghui Ma;Ting Lei
作者机构:
Department of Respiratory and Critical Care Medicine,Lung Cancer Treatment Center,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China;Department of Translational Medicine,Genetron Health(Beijing)Technology,Co.Ltd.,Beijing 102206,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100005,China;Department of Thoracic Surgery,The Second Hospital of Dalian Medical University,Dalian,Liaoning 116023,China;Genetron Health(Beijing)Technology,Co.Ltd.,Beijing 102206,China;Department of Neurosurgery,The First Medical Center of PLA General Hospital,Beijing 100853,China;Department of Neurosurgery,Nanjing Drum Tower Hospital(Nanjing Gulou Yi Yuan),The Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China
文献出处:
引用格式:
[1]Panwen Tian;Xiaoyan Zhang;Sheng Yang;Yu Fang;Hongling Yuan;Wei Li;Honglin Zhu;Fangping Zhao;Jinlei Ding;Yunshu Zhu;Sizhen Wang;Guochen Sun;Hongbin Ni;Tonghui Ma;Ting Lei-.Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients)[J].遗传学报,2022(07):645-653
A类:
M2371,R158H,C238Y,C275R
B类:
Characteristics,TP53,germline,variants,their,correlations,Li,Fraumeni,syndrome,Chinese,tumor,patients,LFS,rare,autosomal,dominant,inheritance,condition,associated,family,cancer,history,well,pathogenic,likely,LP,GV,current,clinical,methods,detecting,limited,Here,retrospectively,investigate,among,by,next,generation,sequencing,evaluate,its,relationship,total,out,have,including,Patients,mainly,found,male,glioma,lung,sarcoma,median,age,diagnosis,significantly,lower,than,that,years,One,LFL,followed,up,Among,types,highest,frequencies,occurred,codon,firstly,identified,This,study,reports,characteristics,pan,These,findings,suggest,analyzing,effective,strategy,identifying,predisposition
AB值:
0.43568
相似文献
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Ming Bai;Meng Wang;Ting Deng;Yuxian Bai;Kai Zang;Zhanhui Miao;Wenlin Gai;Liangzhi Xie;Yi Ba-Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin 300060,China;Department of Gastrointestinal Oncology,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Medical Oncology,Henan Cancer Hospital,The Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou 450008,China;Oncology Department,The First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China;Sinocelltech Ltd.,Beijing 100176,China;Beijing Engineering Research Center of Protein and Antibody,Beijing 100176,China;Cell Culture Engineering Center,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100176,China
Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population
Jianfei Yao;Yunhuan Zhen;Jing Fan;Yuan Gong;Yumeng Ye;Shaohua Guo;Hongyi Liu;Xiaoyun Li;Guosheng Li;Pan Yang;Xiaohui Wang;Danni Liu;Tanxiao Huang;Huiya Cao;Peisu Suo;Yuemin Li;Jingbo Yu;Lele Song-Department of Radiotherapy,the Eighth Medical Center of the Chinese PLA General Hospital,Beijing 100091,China;HaploX Biotechnology,Shenzhen 518057,China;Department of Colorectal Surgery,Affiliated Hospital of Guizhou Medical University,Guiyang 550004,China;International Business School,Beijing Foreign Studies University,Beijing 100089,China;Department of Gastroenterology,the Second Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Experimental Pathology,Beijing Institute of Radiation Medicine,Beijing 100850,China;Department of General Surgery,the First Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Hepatobiliary Surgery,Dalian Municipal Central Hospital,Dalian Medical University,Dalian 116033,China;Comprehensive Liver Cancer Department,the Fifth Medical Center of the Chinese PLA General Hospital,Beijing 100039,China
The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
Li Dong;Hailian Zhang;Huan Zhang;Yingnan Ye;Yanan Cheng;Lijuan Li;Lijuan Wei;Lei Han;Yandong Cao;Shixia Li;Xishan Hao;Juntian Liu;Jinpu Yu-Cancer Molecular Diagnostics Core;The Second Department of Breast Cancer;Cancer Prevention Center,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,China;Department of Oncology,Tianjin Third Central Hospital,Tianjin Institute of Hepatobiliary Disease,Tianjin Key Laboratory of Artificial Cell,Artificial Cell Engineering Technology Research Center of Public Health Ministry,Tianjin 300170,China;Analyses Technology Co.Ltd.,Beijing 102600,China
Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
Yan Li;Lihong Fan;Jianming Zheng;Xiu Nie;Yu Sun;Qin Feng;Shenyi Lian;Wenqi Bai;Weijing Cai;Yanan Yang;Bo Su;Yanfeng Xi;Dongmei Lin-Department of Pathology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Respiration Medicine,Shanghai Tenth People's Hospital,School of Medicine,Tongji University,Shanghai 200072,China;Department of Pathology,Changhai Hospital of Shanghai,Shanghai 200433,China;Department of Pathology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Colorectal Surgery,Shanxi Cancer Hospital,Taiyuan 030013,China;Shanghai Tongshu Biotechnology Co.,Ltd,Shanghai 200120,China;Department of Biochemistry and Molecular Biology,Mayo Clinic,Rochester,MN 55905,USA;Central Laboratory,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China;Department of Pathology,Shanxi Cancer Hospital,Taiyuan 030013,China
An international multicentric phase Ⅲ randomized controlled trial of time-acupoints-space acupuncture for the prevention of chemotherapy-induced fatigue in patients with early stage breast cancer:a study protocol
Saghachian Mahasti;Barry Caroline;Asselain Bernard;LI Yunfen;NIE Jianyun;LIU Dequan;CHEN Dedian;CHEN Chunxin;Laura Estevez;LI Wenhui;Jean-Pierre Armand;ZHU Miansheng;JU Liya-Institute Gustave Roussy,Paris,France;Research Center of Epidemiology and public health,Paris,France;Institute Curie of Paris,Paris,France;Yunnan Cancer Hospital,Third Affiliated Hospital of Kunming Medical University,Kunming,China;PreciMed Platform Europe,Paris,France,,MD Anderson Cancer Hospital,Madrid,Spain;ARIATAS Association pour la Recherche et l'Information de l'Acupuncture Time-Acupoints-Space,Paris,France
Tongue and pulse features of 668 asymptomatic patients infected with the severe acute respiratory syndrome coronavirus 2 omicron variant in Shanghai
ZHANG Wen;CAO Min;SUN Ding;SHI Li;LU Wei;XU Xiangru;ZHOU Shuang;FANG Bangjiang-Department of Emergency,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Rheumatology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Pediatrics,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Nursing,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;College of Acumox and Tuina,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Institute of Emergency and Critical Care Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。